Menu Close

3 reasons to maintain a follow-on allocation

Champ Suthipongchai
Contributor
Champ Suthipongchai is a co-founder and general partner at Creative Ventures, a method-driven deep tech VC firm investing in startups that address the impact of increasing labor shortages, rising healthcare costs and the climate crisis.
More posts by this contributor

3 mistakes to avoid as an emerging manager
3 ways deep tech founders can climb out of pilot purgatory

A venture fund maintaining some allocation for follow-on investments is not unheard of. But should VCs do this?

Follow-on investments won’t ever be the deciding factor in which funds win or lose, but they will continue to distinguish the top decile from the top quartile.

After all, if a company achieves wild success — the goal of any venture investment — then the initial investment will always do better than any follow investment.

So, as investors, why don’t we put everything into that first check to maximize the return? The answer to this requires an exploration of venture mechanics.

Follow-on investments increase the chances of follow-on investment

Follow-on investments are strategic and can often be the difference between a successful next financing round and your portfolio company going bust. They tell new investors that you have skin in the game and believe in your portfolio company, so they should too.

Imagine you’re a lead investor talking to downstream investors about the “best” company in your portfolio. You want them to lead the next round and suggest they do so, but when they ask if you’re joining the round, you tell them no.

Even if your reasoning is that you don’t reserve any capital for follow-on investments, you’re not sending a positive signal.

And what they do next . . . well, what do you think you would do in that position?

There is too much variability to be precise with the runway

Beyond optics, we find many idiosyncratic risks of venture capital. Besides a once-in-a-lifetime pandemic, you cannot always accurately predict things like FDA approval timelines or supply chain constraints, which means your portfolio company’s runway will likely be shorter than what is necessary to get to its next milestone.

Ultimately, there’s too much variability in how far a funding round will take a company, and even the best efforts to estimate runway are often wrong.

What’s more, even if a company reaches its milestone, a small coffin leaves little room to negotiate a good valuation, leaving earlier investors more diluted than they should be.

A venture fund maintaining some allocation for follow-on investments is not unheard of. But should VCs do this?  Read More TechCrunch 

Disclaimer

Innov8 is owned and operated by Rolling Rock Ventures. The information on this website is for general information purposes only. Any information obtained from this website should be reviewed with appropriate parties if there is any concern about the details reported herein. Innov8 is not responsible for its contents, accuracies, and any inaccuracies. Nothing on this site should be construed as professional advice for any individual or situation. This website includes information and content from external sites that is attributed accordingly and is not the intellectual property of Innov8. All feeds ("RSS Feed") and/or their contents contain material which is derived in whole or in part from material supplied by third parties and is protected by national and international copyright and trademark laws. The Site processes all information automatically using automated software without any human intervention or screening. Therefore, the Site is not responsible for any (part) of this content. The copyright of the feeds', including pictures and graphics, and its content belongs to its author or publisher.  Views and statements expressed in the content do not necessarily reflect those of Innov8 or its staff. Care and due diligence has been taken to maintain the accuracy of the information provided on this website. However, neither Innov8 nor the owners, attorneys, management, editorial team or any writers or employees are responsible for its content, errors or any consequences arising from use of the information provided on this website. The Site may modify, suspend, or discontinue any aspect of the RSS Feed at any time, including, without limitation, the availability of any Site content.  The User agrees that all RSS Feeds and news articles are for personal use only and that the User may not resell, lease, license, assign, redistribute or otherwise transfer any portion of the RSS Feed without attribution to the Site and to its originating author. The Site does not represent or warrant that every action taken with regard to your account and related activities in connection with the RSS Feed, including, without limitation, the Site Content, will be lawful in any particular jurisdiction. It is incumbent upon the user to know the laws that pertain to you in your jurisdiction and act lawfully at all times when using the RSS Feed, including, without limitation, the Site Content.